Inflammasome Therapeutics, Inc.

CIK 1989925 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Inflammasome Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
May 4, 2026D0001989925-26-000003
Mar 17, 2025D0002060536-25-000002
Jan 26, 2024D/A0001989925-24-000001
Aug 14, 2023D0001989925-23-000001